| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/02/2000 | CA1340978C Purification, cloning and characterization of the gene for interleukin 1 |
| 04/30/2000 | CA2287604A1 An unusual retrotransposon from the yeast candida albicans |
| 04/30/2000 | CA2269199A1 Mutations of the 5' region of the human 5-ht1a gene, associated proteins of the 5' region and a diagnostic test for major depression and related mental illnesses |
| 04/30/2000 | CA2249046A1 An unusual retrotransposon from the yeast candida albicans |
| 04/27/2000 | WO2000023806A1 Detection and quantification of vancomycin in biological fluids |
| 04/27/2000 | WO2000023622A1 Methods for manipulating complex nucleic acid populations using peptide-labeled oligonucleotides |
| 04/27/2000 | WO2000023621A2 Visualization of rna in living cells |
| 04/27/2000 | WO2000023618A1 Polymorphism in a tgf-beta gene correlated to osteoporosis |
| 04/27/2000 | WO2000023616A2 Method for the exponential amplification of molecular matrices |
| 04/27/2000 | WO2000023615A2 Method for extracting quantitative information relating to an influence on a cellular response |
| 04/27/2000 | WO2000023606A1 Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors |
| 04/27/2000 | WO2000023605A1 cDNA SEQUENCE TRANSCRIBING A mRNA CODING FOR THE TERMINAL OXYDASE ASSOCIATED WITH CAROTENOID BIOSYNTHESIS AND USES |
| 04/27/2000 | WO2000023604A1 Expression vectors containing regulative sequences of stylonychia lemnae for heterologous protein expression in eukaryotic protists and a method for identifying regulative sequences of this type |
| 04/27/2000 | WO2000023603A2 Methods of treatment of type 2 diabetes |
| 04/27/2000 | WO2000023602A2 Regulated expression using conditional er retention domains |
| 04/27/2000 | WO2000023601A1 Delivery system for porcine somatotropin |
| 04/27/2000 | WO2000023600A1 Materials and methods involving conditional aggregation domains |
| 04/27/2000 | WO2000023599A2 Human proteins involved in endoplasmic reticulum protein degradation |
| 04/27/2000 | WO2000023598A1 Aminoacylase and its use in the production of d-aminoacids |
| 04/27/2000 | WO2000023597A2 Tissue-specific promoters for gene expression |
| 04/27/2000 | WO2000023596A1 Cholesterol 25-hydroxylase |
| 04/27/2000 | WO2000023595A1 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 04/27/2000 | WO2000023594A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 04/27/2000 | WO2000023593A2 Molecular pathogenicide mediated plant disease resistance |
| 04/27/2000 | WO2000023592A2 Minimal promoters and uses thereof |
| 04/27/2000 | WO2000023591A2 Secreted protein zsig49 |
| 04/27/2000 | WO2000023590A2 INHIBITION OF CD40-MEDIATED NFλB ACTIVATION |
| 04/27/2000 | WO2000023589A2 Proliferation and apoptosis related proteins |
| 04/27/2000 | WO2000023588A2 G-protein coupled receptors |
| 04/27/2000 | WO2000023587A2 Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e |
| 04/27/2000 | WO2000023586A1 HUMAN PROTEIN Grf40 AND cDNA THEREOF |
| 04/27/2000 | WO2000023585A1 Cardiac troponin i polypeptide fragments and uses in diagnostics |
| 04/27/2000 | WO2000023584A1 Camel, an alternative translation product of the tumour antigen lage-1 |
| 04/27/2000 | WO2000023583A2 p53 BINDING AREAS |
| 04/27/2000 | WO2000023582A1 Gene transfer cell sheet and process for preparing the same |
| 04/27/2000 | WO2000023581A1 Dual reporter system and methods of use therefor |
| 04/27/2000 | WO2000023580A1 A method of affinity separation and ligands for use therein |
| 04/27/2000 | WO2000023579A1 Functionally assembled antigen-specific intact recombinant antibody and a method for production thereof |
| 04/27/2000 | WO2000023578A2 Methods of suppressing flowering in transgenic plants |
| 04/27/2000 | WO2000023577A1 Method for producing chiral carboxylic acids from nitriles with the assistance of a nitrilase or microorganisms which contain a gene for the nitrilase |
| 04/27/2000 | WO2000023575A1 Ups (ugc) |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023570A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | WO2000023569A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | WO2000023567A2 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 04/27/2000 | WO2000023565A2 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | WO2000023564A2 Protein design automation for protein libraries |
| 04/27/2000 | WO2000023473A1 Multiple domain glycoprotein hormones and methods of using |
| 04/27/2000 | WO2000023472A2 Interferon-beta fusion proteins and uses |
| 04/27/2000 | WO2000023470A1 Isolated proteins and nucleic acid molecules having homology to the nip2 protein and uses thereof |
| 04/27/2000 | WO2000023469A2 Fragments of insulin-like growth factor binding protein and insulin-like growth factor, and uses thereof |
| 04/27/2000 | WO2000023468A1 HUMAN PROTEINS STAM2a AND STAM2b AND cDNAS ENCODING THESE MOLECULES |
| 04/27/2000 | WO2000023466A2 Human rna binding proteins |
| 04/27/2000 | WO2000023465A2 Methods and reagents for isolating biologically active peptides |
| 04/27/2000 | WO2000023464A2 Zinc finger binding domains for gnn |
| 04/27/2000 | WO2000023459A1 Inhibitors of platelet activation and recruitment |
| 04/27/2000 | WO2000023458A1 Dna-templated combinatorial library chemistry |
| 04/27/2000 | WO2000023456A1 Functionalized pyrimidine derivatives |
| 04/27/2000 | WO2000023189A1 Device for conducting biochemical and microbiological reactions |
| 04/27/2000 | WO2000023116A1 Adeno-associated vectors for expression of factor viii by target cells |
| 04/27/2000 | WO2000023112A1 Modulation of gene expression by combination therapy |
| 04/27/2000 | WO2000023111A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | WO2000023108A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | WO2000023100A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | WO2000023094A2 Methods of inhibiting platelet activation and recruitment |
| 04/27/2000 | WO2000023092A1 Contulakin-g, analogs thereof and uses therefor |
| 04/27/2000 | WO2000023091A2 Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
| 04/27/2000 | WO2000023087A1 Polyspecific binding molecules and uses thereof |
| 04/27/2000 | WO2000022932A1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
| 04/27/2000 | WO2000012559B1 Monoclonal antibodies against s100 |
| 04/27/2000 | WO2000008149A3 Human neuronal acid-sensitive cationic channels, its cloning and applications |
| 04/27/2000 | WO2000007014A3 Leptin-mediated gene-induction |
| 04/27/2000 | WO2000006754A3 Engineering nematode resistance in solanacae |
| 04/27/2000 | WO2000006742A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/27/2000 | WO2000005407A3 DUPLICATIONS OF HUMAN CHROMOSOME 15q24-25 AND ANXIETY DISORDERS, DIAGNOSTIC METHODS FOR THEIR DETECTION |
| 04/27/2000 | WO2000005386A3 Chorismate biosynthesis enzymes |
| 04/27/2000 | WO2000005377A3 Pc4 transcriptional coactivators |
| 04/27/2000 | WO2000005265A3 Anti-crr2 antibodies and methods of use therefor |
| 04/27/2000 | WO2000004167A3 Genes encoding sulfate assimilation proteins |
| 04/27/2000 | WO2000004166A3 Plant cellulose synthases |
| 04/27/2000 | WO2000004152A3 Androgen receptor coactivators |
| 04/27/2000 | WO2000004141A3 Use of nucleic acid molecules as antiviral agents |
| 04/27/2000 | WO2000003683A3 Liposomal encapsulated nucleic acid-complexes |
| 04/27/2000 | WO2000003008A3 Recombinant haploid or diploid yarrowia lipolytica cells for the functional heterologous expression of cytochrome p450 systems |
| 04/27/2000 | WO2000001827A3 Polyketides, their preparation, and materials for use therein |
| 04/27/2000 | WO2000000618A3 Polyketides and their synthesis |
| 04/27/2000 | WO1999067382A3 Angiopoietin-like growth factor sequences |
| 04/27/2000 | WO1999067282A3 Olfactory receptors and their uses |
| 04/27/2000 | WO1999065531A9 Polymers for delivery of nucleic acids |
| 04/27/2000 | WO1999064586A3 Phagocytic assay method |
| 04/27/2000 | WO1999061596A3 Novel post-transcriptional regulatory elements and uses thereof |
| 04/27/2000 | WO1999057271A9 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 04/27/2000 | WO1999055844A3 Methods for modulating differentiation |
| 04/27/2000 | WO1999050406A9 Growth differentiation factor-9 regulatory sequences and uses therefor |
| 04/27/2000 | WO1999049024A9 Methods and compositions for production of multimeric proteins in transgenic plants |
| 04/27/2000 | WO1999006544A8 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 04/27/2000 | WO1998056811A8 Plant grab proteins |
| 04/27/2000 | DE19950823A1 Quantitative determination of a target nucleic acid in a biological sample comprises amplification using a known number of labeled primer molecules |
| 04/27/2000 | DE19940752A1 Use of an illumination matrix that can be controlled to generate a freely adjustable illumination pattern to produce a microchip |
| 04/27/2000 | DE19851156C1 Isolation of plasmid DNA from a microbial culture comprises acidification and using particles to separate microbial cells from the culture |